Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 242 participants.

Also called NCT02325973

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 242 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02325973
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02325973. Allocation not applicable; no masking; primary purpose diagnostic. Start 2013-06 (registry gives no type); primary completion 2018-02 (actual). Results posted on 2025-08-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI
Acronym
AMICRO
Condition
Multi Vessel Coronary Artery Disease
Condition
STEMI
Intervention (Device)
PressureWire Certus guidewire
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct02325973
Content hash
d906325cc8fd2ffe112d5fea0c8dd68c17e648d89293d02bd0c459939bd38676